| PMP | pain management program; patient management program; patient medication profile; peripheral myelin p... |
|---|---|
| PP | diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa... |
| PPD | packs per day; paraphenylenediamine; percussion and postural drainage; permanent partial disability;... |
| PPP | pain perception profile; palatopharyngoplasty; palmoplantar pustulosis; pentose phosphate pathway; p... |
| PS | pacemaker syndrome; paired stimulation; paradoxical sleep; paraspinal; parasympathetic; Parkinson sy... |
| Win1 protein kinase | <enzyme> A map kinase kinase (mapkk) responsible for osmostress signaling; isolated from schizosaccharomyces pombe Registry number: EC 2.7.10.- Synonym: win1 gene product (26 Jun 1999) |
|---|---|
| platelet basic protein | <protein> Protein that is the precursor of connective tissue activating peptide III and _ thromboglobulin. (18 Nov 1997) |
| wis1 protein kinase | <enzyme> A map kinase kinase homolog; has homology to the serine-threonine family of protein kinases; genbank u81521 Registry number: EC 2.7.10.- Synonym: wis1 gene product, wik1 gene product (26 Jun 1999) |
| Wis4 protein kinase | <enzyme> A map kinase kinase kinase (mapkkk); phosphorylates wis1; genbank y07750 Registry number: EC 2.7.10.- Synonym: wis4 gene product (26 Jun 1999) |
| MUK protein kinase | <enzyme> Related to mapkkk proteins; activates jnk/sapk pathway; genbank d49785 Registry number: EC 2.7.1.- Synonym: protein kinase muk (26 Jun 1999) |
| congenital protein C or s deficiency | This inherited disorder of blood coagulation is characterised by a deficiency of vitamin K dependent plasma proteins (C and s) that are naturally occurring anticoagulants. This disorder results in an increased risk of blood clot formation within the circulatory system. (27 Sep 1997) |
| conjugated protein | A protein that contains atleast one prosthetic group. (09 Oct 1997) |
| copper protein | A protein containing one or more copper ions; e.g., cytochrome c oxidase, phenol oxidase. (05 Mar 2000) |
| core II protein, ubiquinol-cytochrome c reductase | <chemical> Member of the mitochondrial-protein-processing family; protein found in subunits of ubiquinol-cytochrome c reductase; amino acid sequence given in first source Synonym: core II protein, uccreductase (26 Jun 1999) |
| core I protein, ubiquinol-cytochrome c reductase | <chemical> Member of the mitochondrial-protein-processing family; protein found in subunits of ubiquinol-cytochrome c reductase; amino acid sequence given in first source Synonym: core I protein, uccreductase (26 Jun 1999) |
| myelin basic protein | <protein> Major component of the myelin sheath in mammalian CNS. Used as an antigen will induce a allergic encephalitis, possibly a model for some neurodegenerative disorders. (18 Nov 1997) |
| myelin basic protein kinase | <enzyme> Protein from pig brain activates ATP-mg-dependent protein phosphatase; a protein tau kinase; a multisubstrate kinase; in texts written as f subscript a Registry number: EC 2.7.1.- Synonym: protein phosphatase activator fa, glycogen synthase kinase 3, protein kinase f(a), gsk-3, gsk-3alpha, kinase f(a), gsk-3beta, mds1 gene product, p63(samk), src-activated mbp kinase, p63(mapk) (26 Jun 1999) |
| corticosteroid-binding protein | <chemical> Chemical name: Transcortins (12 Dec 1998) |
| myelin p0 protein | A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. (12 Dec 1998) |
| myelin p2 protein | A positively charged protein found in peripheral nervous system myelin. Sensitive immunological techniques have demonstrated that p2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis (neuritis, experimental allergic), the peripheral nervous system counterpart of experimental allergic encephalomyelitis. (12 Dec 1998) |